2023 annual financial data
TScan Therapeutics 2023 Financial results
Direct answer
Revenue was 21.05M USD.
Operating income was -93.46M USD and net income was -89.22M USD.
Operating cash flow was -61.36M USD.
Get free TScan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 21.05M USD
- Operating income
- -93.46M USD
- Net income
- -89.22M USD
- Operating cash flow
- -61.36M USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all TScan Therapeutics financial years